XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Deferred Compensation
Retained Earnings (Deficit)
Accumulated Other Comprehensive (Loss)
Treasury Stock
Beginning balance (in shares) at Jan. 30, 2021   14,641          
Beginning balance at Jan. 30, 2021 $ 93,377 $ 1,464 $ 148,519 $ 3,165 $ (42,790) $ (13,816) $ (3,165)
Beginning balance, treasury stock (in shares) at Jan. 30, 2021             (57)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   348          
Vesting of stock awards 0 $ 35 (35)        
Stock-based compensation expense 30,942   30,942        
Purchase and retirement of shares (in shares)   (1,025)          
Purchase and retirement of common stock (85,648) $ (103) (19,078)   (66,467)    
Other comprehensive loss (370)         (370)  
Deferral of common stock into deferred compensation plan 0     278     $ (278)
Deferral of common stock into deferred compensation plan (in shares)             (4)
Net income (loss) 187,171       187,171    
Ending balance (in shares) at Jan. 29, 2022   13,964          
Ending balance at Jan. 29, 2022 225,472 $ 1,396 160,348 3,443 77,914 (14,186) $ (3,443)
Ending balance, treasury stock (in shares) at Jan. 29, 2022             (61)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   281          
Vesting of stock awards 0 $ 28 (28)        
Stock-based compensation expense 29,150   29,150        
Purchase and retirement of shares (in shares)   (1,953)          
Purchase and retirement of common stock (92,945) $ (195) (38,514)   (54,236)    
Other comprehensive loss (2,061)         (2,061)  
Deferral of common stock into deferred compensation plan 0     293     $ (293)
Deferral of common stock into deferred compensation plan (in shares)             (6)
Net income (loss) $ (1,138)       (1,138)    
Ending balance (in shares) at Jan. 28, 2023 12,225 12,292          
Ending balance at Jan. 28, 2023 $ 158,478 $ 1,229 150,956 3,736 22,540 (16,247) $ (3,736)
Ending balance, treasury stock (in shares) at Jan. 28, 2023 (67)           (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of stock awards (in shares)   503          
Vesting of stock awards $ 0 $ 51 (51)        
Stock-based compensation expense (5,576)   (5,576)        
Purchase and retirement of shares (in shares)   (210)          
Purchase and retirement of common stock (7,131) $ (21) (4,246)   (2,864)    
Other comprehensive loss (249)         (249)  
Deferral of common stock into deferred compensation plan 0     (827)     $ 827
Deferral of common stock into deferred compensation plan (in shares)             11
Net income (loss) $ (154,541)       (154,541)    
Ending balance (in shares) at Feb. 03, 2024 12,529 12,585          
Ending balance at Feb. 03, 2024 $ (9,019) $ 1,259 $ 141,083 $ 2,909 $ (134,865) $ (16,496) $ (2,909)
Ending balance, treasury stock (in shares) at Feb. 03, 2024 (56)           (56)